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ess: ashammam2@yahoSummary Introduction: The study was conducted to assess the clinical and
polysomnographic characteristics of patients with sleep-related breathing disorders
who presented to the intensive care unit (ICU) with acute respiratory failure and the
practicability of performing polysomnography for such patients.
Material and methods: We analyzed clinical presentation, cause of admission to
the ICU, ICU course and outcome of 11 subjects with acute respiratory failure who
were diagnosed to have sleep disordered breathing based on polysomnography
between October 1999 and January 2003. Subjects were compared to 11 patients
with obstructive sleep apnea syndrome matched to each subject using body mass
index, age and apnea hypopnea index measured at the time of diagnosis (matched
comparison group). Repeated arterial blood gases and polysomnography were done
for 8 subjects compliant to treatment 6–8 months after discharge from ICU.
Results: The reason for ICU admission for all subjects was hypercapnic respiratory
failure. pH and daytime PaO2 were significantly lower in studied subjects compared
to the matched comparison group while awake daytime PaCO2 was significantly
higher. Subjects had frequent episodes of hypoventilation. Follow up arterial blood
gases and polysomnography 6–8 months after treatment (non-invasive ventilation) in
compliant subjects showed significant improvement in all blood gases para-
meters.
Conclusions: Early polysomnography (or portable cardio-respiratory monitoring)
allows accurate diagnosis and institution of the appropriate ventilation method
Further studies should assess the evolution of respiratory drive in patients with sleep
disordered breathing and hypercapnia under therapy (non-invasive ventilation).
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Respiratory failure in sleep disordered breathing 719Introduction
Sleep disordered breathing is a relatively common
disorder.1 Serious complications like hypertension,2
ischemic heart disease,3 stroke4 and pulmonary
hypertension5 have been reported secondary to
sleep disordered breathing. Patients with obstruc-
tive sleep apnea syndrome have been shown to have
increased mortality,6 which has been attributed to
comorbid conditions and complications of obstruc-
tive sleep apnea syndrome like obesity, hypertension
and ischemic heart disease. The association be-
tween sudden death and sleep disordered breathing
has been reported earlier in patients labeled with
the diagnosis of ‘‘Pickwickian syndrome’’.7 The
relationship between sleep disordered breathing
and acute respiratory failure is not well established.
Few papers in the literature addressed the issue of
acute respiratory failure in patients with sleep
disordered breathing.8–10 Patients with sleep dis-
ordered breathing and respiratory failure may be
misdiagnosed as having chronic obstructive pulmon-
ary disease (COPD) or chronic heart disease resulting
in delay in receiving the appropriate treatment.
This study was conducted to describe the clinical
and polysomnographic characteristics of patients
with sleep-related breathing disorders who present
to the ICU with acute respiratory failure and to
assess the practicability of performing polysomno-
graphy in this group of patients.Material and methods
The study was conducted at King Khalid University
Hospital (KKUH), which is a 650 beds tertiary care
hospital that accepts referrals from different
regions of Saudi Arabia. Around 60–70 patients a
year are admitted to the medical intensive care
unit (ICU) for respiratory failure. Data from eleven
subjects with acute respiratory failure diagnosed to
have sleep-related breathing disorders (based on
polysomnography) between October 1999 and
January 2003 during ICU admission were analyzed
for clinical presentation, reason for ICU admission,
management, response to treatment and outcome.
The diagnosis of obstructive sleep apnea was
already established in one subject and continuous
positive airway pressure (CPAP) was prescribed,
however, he was not compliant to treatment. The
remaining ten subjects were not known to have
sleep-related breathing disorders before.
The diagnosis of sleep disordered breathing was
entertained based on clinical suspicion with a
typical history obtained from relatives (snoring,witnessed apnea by family members or excessive
daytime sleepiness), body habitus associated with
witnessed apneas by the ICU staff or repetitive
desaturation using pulse oximeter with fast sam-
pling rate (3–10 s) and negative history for alcohol,
hypnotic or psychotropic drug dependence. Apart
from occasional linear atelectasis, chest radio-
graphs showed no other abnormalities. Polysomno-
graphy was performed before discharge from ICU.
For one subject, polysomnography was performed
in the ICU. The remaining subjects were trans-
ferred to the nearby sleep disorders center
accompanied by an ICU nurse. Polysomnography
was not performed for subject number 5 as he was
diagnosed before in another hospital to have
obstructive sleep apnea syndrome. Critical care
monitoring was continued while in the sleep
disorders center. No polysomnography was per-
formed for patients during mechanical ventilation.
None of the other subjects was known to have
chronic lung diseases nor history of skeletal or
neuromuscular diseases. Ventilated patients re-
ceived sedation during intubation only. After that,
no sedation was given to them. For ventilated
patients, polysomnography was performed 3–4 days
after extubation. While in the ICU before poly-
somnography was performed, subjects were started
on Bi-level positive airway pressure (BilevelPAP)
(IPAP 10 cm H2O and EPAP 6 cm H2O). Treatment
modality and pressures were adjusted later based
on the polysomnographic findings.
Subjects were compared to 11 patients with
obstructive sleep apnea syndrome matched to each
subject using body mass index, age and apnea
hypopnea index measured at the time of diagnosis
(matched comparison group). The comparison group
comprised of consecutive patients referred electively
to the sleep disorders center during the study period
for obstructive sleep apnea syndrome diagnosis.
A data entry sheet was completed for each
subject assessing; demographic data, reason for
ICU admission, duration of ICU stay, co-morbid
conditions, medications, investigations, and me-
chanical ventilation methods. Repeated arterial
blood gas analysis and polysomnography were done
for eight subjects compliant to treatment (CPAP or
bilevel positive airway pressure (BilevelPAP)) 6–8
months after discharge from ICU. Pulmonary func-
tion testing (FEV1, FVC) was performed for subjects
before discharge from the hospital.Polysomnography
Alice-4 diagnostic equipment from Respironics, Inc,
Murrysville, Pennsylvania, USA was used in data
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A. BaHammam et al.720acquisition. Data were then downloaded in to IBM-
PC. The patient was connected to the monitoring
machine by a trained technician. The technician
stayed with the patient throughout the study.
During the study, the following parameters were
monitored: four electro-encephalography (EEG)
(C1-A4, C2-A3, O1-A4, O2-A3), chin electromyogra-
phy (EMG), electro-oculography (EOG) (eye move-
ment), leg EMG, electro-cardiography (ECG),
oxygen saturation, chest and abdominal wall move-
ments, two air flow signals (nasal prong pressure
and thermistor), sleep position, and microphone for
snoring.
During polysomnography the following protocol
was used. During the initial 1–3 h, the patient was
studied without intervention to identify the nature
and severity of the underlying sleep disordered
breathing. After that, treatment was started. CPAP
(Respironics Inc, Muraysville, PA) was attempted
initially. BilevelPAP (Respironics Inc, Muraysville,
PA) was started if the patient could not tolerate
CPAP due to persistent massive mask air leakage or
discomfort exhaling against positive pressure, or
the patient had frequent episodes of hypoventila-
tion without airway obstruction (revealed as a
plateau on the inspiratory flow signal using nasal
prong pressure without a thoracoabdominal para-
dox). Pressure titration was performed according to
a described protocol.11 Oxygen supplementation
was added if the patient continued to have
hypoxemia despite complete elimination of the
obstructive respiratory events. Once the mode of
support, pressure level and level of oxygen supple-
mentation have been determined, the patient was
transferred back to the ICU. The needed support
measures were instituted in the ICU using mechan-
ical ventilators in the ICU with internal alarms and
monitors.
All sleep studies were analyzed by the principal
author to maximize the inter-scorer and intra-
scorer reliability.Analysis and scoring of the sleep studies
Analysis and scoring of the electronic raw data was
done manually page by page evaluating time in bed,
total sleep time (TST), sleep stages, and arousal
index according to established criteria.12,13 Reports
were generated using the Alice-4 software. Standard
definitions were used to classify central, obstructive
apneas and hypopneas and central hypoventila-
tion.14 Apnea was defined as the cessation of airflow
X10 s, and hypopnea as a recognizable, transient
reduction of airflow (450%) for X10 s using
nasal prong pressure flow signal. The diagnosis ofobstructive sleep apnea syndrome was based on
history of snoring and excessive daytime sleepiness
and apnea hypopnea index of410h. Hypoventila-
tion was defined as sustained oxygen desaturation
that was not associated with obstructive apneas or
hypopneas or periodic breathing.15–17 Patients with
hypoventilation were labeled as having sleep hypo-
ventilation syndrome (SHVS).
During follow up visits, compliance to treatment
(CPAP, BilevelPAP and home oxygen) was assessed
by asking family members who are living with the
patient. Good compliance was defined as using
CPAP or BilevelPAP more than five nights per
week, poor compliance as less than three nights
per week, and intermediate compliance between
3 and 5 nights per week. For one patient, his
machine was provided with a data-recording card
that allowed objective assessment of compliance
during every visit.Statistical analysis
Data are expressed in text and tables as mean7-
standard error of mean (SEM). Comparisons between
subjects and their matched comparison group were
made using t-test. For comparing the studied
subjects before and after treatment, paired t-test
was used. Results were considered statistically
significant at the Po0:05:Results
Eleven subjects were included in the study, 6 males
and 5 females. Table 1 shows the characteristics of
all 11 subjects on admission. All subjects were
admitted to the ICU due to hypercapnic respiratory
failure. All studied subjects were discharged to the
ward, in which ten of them were discharged home
later. Subject number 5 required re-admission to
ICU two days after transfer to the ward as he
refused to use CPAP. On his second admission, he
developed severe sepsis and expired after 3 days.
Subject number 3, was sent home in a stable
condition on BilevelPAP and home oxygen. How-
ever, she was not compliant to treatment and
refused to use BilevelPAP or to have tracheostomy.
Three months after discharge, she developed
hypercapnic respiratory failure and congestive
heart failure necessitating intubation and mechan-
ical ventilation. The patient expired during that
admission. Unfortunately, the details of her last
admission were unavailable since she was admitted
to another hospital. Subject number 10 refused to
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Table 1 Characteristics of the studied subjects.
Subject
No
Sex Reason for
admission
Cor-
pulmonale
Apnea
known
BP GCS APACHE
score
Mechanical
ventilation
PSG diagnosis ICU stay
(days)
Outcome
1 M Hypercapnic RF Yes No 130/70 13 24 No SHVS+OSA 4 Discharged
2 M Hypercapnic RF Yes No 145/69 11 17 No SHVS+OSA 7 Discharged
3 F Hypercapnic RF Yes No 140/90 7 17 Yes SHVS+OSA 11 Discharged*
4 M Hypercapnic RF Yes No 147/70 15 24 No SHVS+OSA 5 Discharged
5 M Hypercapnic RF Yes Yes 136/58 7 10 Yes OSA 7 Discharged**
6 M Hypercapnic RF Yes No 120/80 15 19 No SHVS+OSA 3 Discharged
7 M Hypercapnic RF Yes No 160/70 15 32 No OSA 6 Discharged
8 F Hypercapnic RF Yes No 160/100 15 25 No SHVS+OSA 14 Discharged
9 F Hypercapnic RF Yes No 130/70 15 30 No SHVS+OSA 4 Discharged
10 F Hypercapnic RF Yes No 150/70 11 21 Yes SHVS 8 Discharged
11 F Hypercapnic RF Yes No 124/60 13 21 No SHVS+OSA 3 Discharged
Mean
(SEM)
140/74
(4.1/3.7)
12.5 (0.9) 21.8 (1.9) 6.5 (1)
CHF: congestive heart failure; GCS: Glasgow coma scale (range from 3 (poor)-15 (good)); APACHE: Acute Physiology and Chronic Health Evaluation score (range 0–71, increasing score
represents a greater severity of illness); RF: respiratory failure; SHVS: sleep hypoventilation syndrome; OSA: obstructive sleep apnea.
*Discharged home but readmitted again to ICU few months later and expired.
**Discharged to the ward and readmitted few days later with septic shock and expired.
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A. BaHammam et al.722use BilevelPAP. She was admitted 4 times that year
following her diagnosis. Subject number 11 did not
come for follow up.
All subjects were diagnosed to have pulmonary
hypertension based on clinical picture and echo-
cardiographic findings. Repeated echocardiography
for subject numbers 1 and 4 one year after
treatment revealed normalization of the pulmonary
artery pressure (no data was available for other
subjects).
Table 2 summarizes the characteristics of sub-
jects and their matched comparison group. Mean
age for subjects was 5374.9 years and body mass
index was 47.774.1 kg/m2. Mean age of the
comparison group was 54.273.1 years and body
mass index was 44.171.9 kg/m2. Two subjects
were known to have hypothyroidism and were on
thyroid hormone replacement at the time of
admission. Thyroid function was normal for the
remaining subjects and the matched comparison
group. Both subjects and their matched comparison
group were identical in the apnea hypopnea index.
However, compared to the comparison group,
subjects spent more time with PaO2o90%, had
higher desaturation index and their lowest re-
corded oxygen saturation was significantly lower.
Desaturation index was higher in subjects because
this group had frequent episodes of sustained
oxygen desaturation that was not associated with
obstructive apneas, hypopneas or periodic breath-
ing. Those episodes were not scored as apneas or
hypopneas and were labeled as episodes of hypo-
ventilation. The affected subjects were diagnosed
to have sleep hypoventilation syndrome. Nine
subjects were labeled as having sleep hypoventila-
tion syndrome.
pH was significantly lower in subjects
(7.2970.02) compared to their matched compar-
ison group (7.470.01) (Po0:05). Awake daytime
PaO2 was also significantly lower in subjectsTable 2 Comparison between subjects and their mat
findings upon diagnosis and arterial blood gases paramete
Age
Body mass index
Apnea hypopnea index
Time with oxygen saturation o90% (% of total sleep time
Desaturation index
Minimum oxygen saturation
pH
PaCO2 (mmHg)
PaO2 (mmHg)
HCO3 (mmol/L)compared to their matched comparison group
(Po0:05). All subjects had daytime hypercapnia
with PaCO2 ranging from 52.2 to 116mmHg
(77.975.1).
Pulmonary function testing was performed in all
subjects before discharge from the hospital. It
showed obstructive pattern in subject numbers 3, 8
and 11. Pulmonary function measurements were
within normal limits for the rest of the subjects.
Table 3 summarizes the treatment modalities
used. Ten of the studied subjects required Bilevel-
PAP and supplemental oxygen. One subject was
controlled by CPAP alone. Eight subjects were
compliant to treatment. Six to eight months after
treatment, all compliant subjects did not require
oxygen supplementation while awake. However,
three of them continued to need nocturnal oxygen
hooked to BilevelPAP during sleep.
Table 4 summarizes the arterial blood gas
parameters on admission and 6–8 months after
treatment in compliant subjects. It demonstrates
significant improvement in all parameters.Discussion
Obesity is known to be a major risk factor for a
range of respiratory disorders.18 The present study
describes an unusual cause of acute respiratory
failure necessitating ICU admission in obese pa-
tients. We described 11 subjects with sleep-related
breathing disorders who developed severe hyper-
capnic respiratory failure necessitating ICU admis-
sion. Early diagnosis allowed early institution of
appropriate treatment, hence, avoiding the need
for invasive mechanical ventilation in most sub-
jects. This study stresses the importance of early
sleep study in patients with acute respiratory
failure suspected of having sleep-related breathingched comparison group (reported polysomnographic
rs upon admission to the ICU).
Subjects Comparison group P value
53.374.9 54.273.1 NS
47.774.1 44.171.9 NS
45.479.0 48.875.8 NS
) 76.976.9 33.477.9 o0.05
78.5710.3 56.173.8 o0.05
63.173.5 76.678.4 o0.05
7.2970.02 7.470.01 o0.05
77.975.1 36.371.7 o0.05
48.372.9 76.273.3 o0.05
38.872.2 24.373.6 0.05
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Table 3 Treatment modalities for studied subjects on diagnosis and 6-8 months after treatment.
Treatment modality Follow up after 6–8 months
Subject
no
Treatment
modality
IPAP
cmH2O
EPAP
cmH2O
Need for
daytime O2
Compliance
with treatment
Need for
PPV
Need for
daytime O2
Need for
nocturnal O2
1 BiPAP+O2 8 4 Yes Good Yes No Yes
2 BiPAP+O2 8 4 Yes Good Yes No No
3 BiPAP+O2 10 6 Yes Poor Yes Yes Yes
4 BiPAP+O2 20 16 Yes Good Yes No Yes
5 BiPAP+O2 10 6 Yes Poor No data No data No data
6 BiPAP+O2 18 14 Yes Good Yes No No
7 CPAP — 12 No Good Yes No No
8 BiPAP+O2 8 4 Yes Good Yes No No
9 BiPAP+O2 12 8 No Good Yes No No
10 BiPAP+O2 10 6 Yes Poor Yes Yes Yes
11 BiPAP+O2 10 6 Yes No data No data No data No data
IPAP: inspiratory positive airway pressure, EPAP: expiratory positive airway pressure; BiPAP: bilevel positive airway pressure, O2:
Oxygen.
Table 4 Arterial blood gases parameters in compliant subjects, before treatment with non-invasive ventilation
and 6–8 months after treatment.
Before treatment After treatment P value
pH 7.370.01 7.470.004 o0.05
PaCO2 (mmHg) 79.478.1 49.174.6 0.05
PaO2 (mmHg) 45.773.7 71.173.2 o0.05
HCO3 (mmol/L) 40.572.9 27.170.8 o0.05
Respiratory failure in sleep disordered breathing 723disorders. In the present study, we used full
polysomnography due to the vicinity of the sleep
disorders center to the ICU. However, portable
sleep diagnostic system may suffice. Sleep disor-
dered breathing is overlooked as a cause of acute
respiratory failure.9,10 In obese patients with un-
explained hypercapnic respiratory failure, sleep
disordered breathing should be considered as a
possible cause. Ventilating this group of patients
via non-invasive ventilation is safe and very
effective in this setting.
Although the apnea hypopnea index, body mass
index and age were comparable in studied subjects
and their matched comparison group, all but two
subjects had sleep hypoventilation syndrome and
hypercapnia compared to none in the comparison
group. Our findings contrast with Eugene et al.8
who reported obstructive sleep apnea syndrome
only in their group of apnea patients with acute
respiratory failure. However, later reports9,10 con-
curred with our findings where high prevalence of
sleep hypoventilation syndrome was reported in
patients with sleep disordered breathing admittedto the ICU with acute respiratory failure. There-
fore, it seems that the severity of the apnea
hypopnea index may not be a good predictor
of apnea patients who may develop respiratory
failure. Based on our data and previous reports
(Table 5), it seems that middle-aged obese patients
with sleep disordered breathing, hypercapnia and
hypoxemia are at a higher risk of having acute
respiratory failure. Clinicians should be alert in
managing apneic patients with hypoventilation,
daytime hypercapnia and hypoxemia, as these
patients may have a greater risk tendency to
develop respiratory failure. Our findings demon-
strate that CPAP may not be effective in some
patients due to the persistent hypoventilation. This
stresses the importance of performing polysomno-
graphy to document the pattern of breathing
and response to treatment. All studied subjects
but one had a combination of obstructive sleep
apnea and sleep hypoventilation syndrome. That
explains the high EPAP used in some cases. EPAP is
needed to prevent upper airway closure during
expiration. Fibro-optic imaging studies in patients
ARTICLE IN PRESS
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A. BaHammam et al.724with obstructive sleep apnea have demonstrated
that upper airway narrowing begins prior to
inspiration in sleeping humans.19
Subjects compliant to therapy had significant
improvement in their daytime PaCO2. Six of them
did not require daytime oxygen supplementation
6–8 months after institution of nocturnal non-
invasive ventilation treatment. Earlier studies using
tracheostomy and then CPAP led to the clear
recognition that treating obstructive sleep apnea
syndrome may lead to improvement in hypercap-
nia.20,21 Nocturnal non-invasive ventilation may
help normalize PaCO2 due to changes in respiratory
drive that occurs as a consequence of improved
upper airway mechanics.22 Sullivan et al., have
previously reported that patients with obstructive
sleep apnea and daytime hypercapnia have low or
absent hypoxic responsiveness.23 Moreover, in a
group of 13 obese patients with obstructive sleep
apnea (half of them were hypercapnic), Garay et
al.24 have observed a diminished ventilatory re-
sponse to hypoxia and hypercapnia in patients who
were hypoxemic and hypercapnic, respectively.
These results suggest that repeated apnea could
favor a diminished ventilatory response to hypoxia
and hypercapnia.25 Several factors might have
contributed to the improvement in daytime PaO2.
Theoretically, positive pressure ventilation might
have improved lung mechanics by decreasing the
incidence of atelectasis. Moreover, the reduction in
pulmonary artery pressure and the daytime PaCO2
will result in improvement in daytime PaO2.
Our study also demonstrated the safety and
feasibility of performing polysomnography in the
sleep disorders center for ICU patients with
clinical suspicion of sleep-disordered breathing.
We described the protocol used to perform
polysomnography in such patients. Performing
polysomnography for ICU patients with acute
respiratory failure and clinical suspicion of sleep-
disordered breathing will allow a more accurate
diagnosis and appropriate institution of manage-
ment protocols. However, if performing full poly-
somnography is not feasible, portable sleep
diagnostic system can be used.
This study has some limitations. The number of
studied subjects is relatively small. However,
previous studies reported small number of patients
with the largest reporting 14 patients only8–10
(Table 5). Another limitation is the unavailability
of follow up data on all subjects as some subjects
did not come for follow up.
In summary, this study showed that sleep
disordered breathing can be the cause of acute
respiratory failure in obese patients admitted to
the ICU. Intensivists and respirologists should have
ARTICLE IN PRESS
Respiratory failure in sleep disordered breathing 725a high index of suspicion especially in obese
patients with hypercapnia. Our study also shows
that polysomnography is feasible and efficacious in
acutely ill patients. Early polysomnography (or
portable cardio-respiratory monitoring) allows ac-
curate diagnosis and institution of appropriate
ventilation method, which may lead to avoidance
of mechanical ventilation and reduction in morbid-
ity. Compliance to treatment results in improve-
ment of daytime hypercapnia and hypoxemia.
Further studies with a larger number of subjects
and sufficient records of follow up visits should be
done to supplement, explore and confirm our
observations. Furthermore, we need more studies
on the evolution of respiratory drive in patients
with sleep disordered breathing and hypercapnia
under therapy (non-invasive ventilation).References
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